Basic Information
Reponex Pharmaceuticals A/S is a clinical-stage biopharmaceutical company and now part of Pharma Equity Group A/S. Reponex Pharmaceuticals A/S is dedicated to developing new and effective treatments for diseases that have a significant impact on patients and society, where current treatment options are either lacking or in need of improvement. These diseases are acute or life-threatening, such as bacterial peritonitis and cancer, or they may be chronic conditions that reduce lifespan and quality of life and potentially shorten life expectancy, including inflammatory bowel disease or chronic disease complications like disabling non-healing skin ulcers in patients with diabetes or venous insufficiency.